4 Merger and Acquisition Stock Stories Not to be Missed

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Google (NASDAQ:GOOG): Current price $824.71

This week, Google purchased the Canadian neural networks startup DNNresearch, which is a three-person team working out of the Department of Computer Science at the University of Toronto. Financials of the transaction were not reported. All three members of the team will be employed by Google along with continuing their research at the university. DNNresearch was incorporated in 2012 by university professor Geoffrey Hinton and two of his graduate students, Alex Krizhevsky and Ilya Sutskever. Google appears to have pulled off an “acqui-hire” in this case.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

GOOG

Shire (NASDAQ:SHPG): Current price $91.89

Shire has acquired the privately held biotech firm Premacure of Uppsala, Sweden, which develops a protein replacement therapy, currently in Phase II development,  for the prevention of retinopathy of prematurity. The condition is a rare and potentially blinding eye disorder that primarily affects premature infants and is one of the most common causes of visual loss in childhood. Presently, only symptomatic treatment is available. Shire will purchase Premacure for an upfront payment and certain contingent payments calculated on the achievement of pre-specified development and commercial milestones. This purchase underscores and broadens Shire’s commitment to bringing innovative therapies to patients with rare disorders worldwide.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

SHPG

Advent Software (NASDAQ:ADVS): Current price $28.67

The accounting software company is exploring a sale and has recruited Frank Quattrone’s investment bank Qatalyst Partners to spearhead the endeavor, said inside sources on Tuesday. Advent shares popped on the news and were up by 11 percent in late afternoon trading in New York, giving the firm a market value at almost $1.5 billion. The sources reported that thus far Advent has enticed interest primarily from private equity firms, and that the process is in the second round of bidding.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

ADVS

Complete Genomics (NASDAQ:GNOM): Current price $3.14

BGI-Shenzhen and Complete Genomics announced Tuesday that they have obtained permission from the State Administration of Foreign Exchange of the People’s Republic of China concerning BGI’s proposed purchase of the former, through the previously reported agreement and plan of merger. Therefore, all relevant regulatory approvals in connection with the proposed acquisition have been received.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

GNOM

Don’t Miss: Lenovo’s BlackBerry Acquisition: Debunked Again?

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business